Blockchain Registration Transaction Record

Aclarion Hires Daniel Keefe to Lead Western U.S. Nociscan Growth

Aclarion appoints Daniel Keefe as Commercial Director, Western U.S., to drive adoption of Nociscan, an AI-powered platform for chronic low back pain diagnosis with 97% surgical success rate.

This news matters because chronic low back pain affects 266 million people worldwide, and Aclarion's Nociscan platform offers a noninvasive, AI-driven solution to precisely identify pain-generating discs, potentially improving surgical success rates to 97%. The appointment of a seasoned commercial leader like Daniel Keefe signals accelerating adoption and expanded access to this transformative diagnostic tool, directly impacting patients, spine surgeons, and healthcare systems seeking more effective treatment strategies for a debilitating condition.